Rainbow Childrens Medicare Ltd

Rainbow Child. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Rainbow Childrens Medicare Ltd

₹ 1,556 -4.16%
25 Jul - close price
rainbowhospitals.in BSE: 543524 NSE: RAINBOW
About

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]

Key Points

Business Overview[1]
The company operates 19 hospitals and 5 clinics across 6 cities, with a total bed capacity of 1,935. It specializes in pediatric healthcare under "Rainbow Children's Hospital" and women's healthcare under "Birthright by Rainbow."

Website BSE NSE
  • Market Cap ₹ 15,806 Cr.
  • Current Price ₹ 1,556
  • High / Low ₹ 1,710 / 1,129
  • Stock P/E 63.1
  • Book Value ₹ 147
  • Dividend Yield 0.19 %
  • ROCE 18.3 %
  • ROE 16.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's median sales growth is 20.5% of last 10 years
  • Company's working capital requirements have reduced from 51.9 days to 24.4 days

Cons

  • Stock is trading at 10.6 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
223 298 291 303 270 319 322 326 315 404 382 354 335
145 193 189 205 188 204 208 223 225 260 251 243 235
Operating Profit 77 105 102 98 83 114 114 103 90 143 130 111 100
OPM % 35% 35% 35% 32% 31% 36% 35% 32% 29% 36% 34% 31% 30%
6 3 8 9 8 9 8 12 11 11 13 14 19
Interest 13 12 13 13 14 13 14 16 17 17 17 17 17
Depreciation 20 21 21 22 24 25 26 31 32 33 34 33 33
Profit before tax 50 75 76 72 53 86 83 68 52 104 92 75 69
Tax % 25% 26% 25% 22% 25% 25% 26% 26% 25% 25% 27% 27% 25%
38 56 57 56 39 64 61 50 39 77 67 55 52
EPS in Rs 3.70 5.50 5.60 5.48 3.87 6.30 6.02 4.97 3.82 7.62 6.60 5.37 5.09
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
148 234 402 543 695 614 925 1,114 1,237 1,455 1,474
110 204 332 430 486 449 626 729 820 976 990
Operating Profit 39 30 70 112 209 166 299 385 417 479 484
OPM % 26% 13% 17% 21% 30% 27% 32% 35% 34% 33% 33%
10 16 10 8 12 12 21 27 37 49 57
Interest 2 3 4 6 46 44 53 55 59 74 70
Depreciation 7 18 28 36 65 68 77 84 105 132 132
Profit before tax 40 24 47 79 109 66 190 273 289 322 339
Tax % 33% 28% 22% 25% 35% 25% 25% 25% 26% 26%
27 17 36 60 71 49 142 206 215 238 251
EPS in Rs 28.65 18.39 8.30 13.56 16.12 11.24 15.13 20.28 21.17 23.40 24.68
Dividend Payout % 7% 11% 12% 7% 12% 0% 13% 15% 14% 13%
Compounded Sales Growth
10 Years: 26%
5 Years: 16%
3 Years: 16%
TTM: 15%
Compounded Profit Growth
10 Years: 24%
5 Years: 27%
3 Years: 18%
TTM: 17%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 47%
1 Year: 33%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 19%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 9 9 44 44 44 44 94 102 102 102
Reserves 170 272 304 359 371 421 531 987 1,184 1,387
11 24 24 61 480 495 559 538 735 734
31 40 73 91 117 109 101 132 130 131
Total Liabilities 221 346 445 555 1,012 1,070 1,285 1,759 2,150 2,354
54 123 293 333 663 722 813 891 1,219 1,368
CWIP 30 28 12 21 43 29 6 23 20 28
Investments 24 2 0 5 24 37 42 105 346 596
113 193 140 197 282 282 424 740 566 362
Total Assets 221 346 445 555 1,012 1,070 1,285 1,759 2,150 2,354

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
23 17 48 96 178 142 214 315 306 385
-21 -107 -42 -125 -123 -87 -169 -460 -214 -263
-4 92 -7 31 -54 -56 -41 148 -97 -113
Net Cash Flow -1 2 -2 2 1 -2 4 2 -4 9

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 11 10 14 19 19 27 16 19 21 20
Inventory Days 39 35 36 32 52 35 27 43 52 44
Days Payable 130 107 148 153 152 190 115 195 177 165
Cash Conversion Cycle -80 -62 -97 -102 -80 -128 -72 -133 -104 -102
Working Capital Days -16 -30 -28 -5 9 12 -5 83 48 24
ROCE % 7% 20% 23% 12% 23% 24% 19% 18%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
49.83% 49.83% 49.83% 49.83% 49.83% 49.83% 49.83% 49.87% 49.85% 49.85% 49.85% 49.85%
15.89% 20.82% 19.82% 20.20% 21.63% 22.32% 24.04% 24.78% 25.12% 25.12% 23.69% 23.60%
10.25% 13.90% 15.38% 15.36% 15.39% 15.62% 14.76% 13.81% 13.84% 13.87% 15.31% 15.44%
24.02% 15.45% 14.98% 14.63% 13.14% 12.23% 11.37% 11.53% 11.20% 11.16% 11.14% 11.11%
No. of Shareholders 91,53079,22475,61174,69079,18780,47177,15278,55777,52478,76479,09280,320

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls